Polymer genomics

Alexander V. Kabanov, Elena V. Batrakova, Simon Sherman, Valery Y. Alakhov

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

Biological activities of biocompatible synthetic polymers used in drug delivery, gene delivery, vaccine development or biomaterial surface modification are discussed. Synthetic polymers display selective phenotypic effects in cells and in the body, affecting signal transduction mechanisms involving inflammation, differentiation, proliferation, and apoptosis. These effects are realized as a result of interactions of water-soluble polymers with plasma cell membranes, delivery of polymers to intracellular organelles, and at the sites of cell contacts with polymer-coated surfaces. The ability of the cells and organisms to respond to the effects of these polymers can be dependent on phenotype or genotype. In selected cases, polymer agents can bypass limitations on biological response imposed by the genotype; for example, achievement of phenotypic correction of immune response by polyelectrolytes. Overall, these effects are relatively weak as they do not result in cytotoxicity or major toxicities in the body. However, when combined with specific biological agents, such as cytotoxic agents, bacterial DNA or antigens, either by mixing or by covalent conjugation, the polymers can drastically alter specific genetically controlled responses to these agents. Collectively these studies propose the need for thorough assessment of pharmacogenomic effects of polymer materials in order to maximize the clinical outcomes and understand the pharmacological and toxicological effects of polymer formulations of biological agents - polymer genomics.

Original languageEnglish (US)
Pages (from-to)173-198
Number of pages26
JournalAdvances in Polymer Science
Volume193
Issue number1
DOIs
StatePublished - Dec 1 2006

Fingerprint

Polymers
Biological Factors
Cell membranes
Genomics
Bacterial Antigens
Bacterial DNA
Signal transduction
Vaccines
Cytotoxins
Biocompatible Materials
Cell death
Antigens
Cytotoxicity
Bioactivity
Polyelectrolytes
Drug delivery
Biomaterials
Toxicity
Surface treatment
DNA

Keywords

  • Artificial vaccines
  • DNA microarray
  • Drug resistance
  • Phenotype
  • Signal transduction

ASJC Scopus subject areas

  • Chemical Engineering(all)
  • Organic Chemistry
  • Polymers and Plastics

Cite this

Kabanov, A. V., Batrakova, E. V., Sherman, S., & Alakhov, V. Y. (2006). Polymer genomics. Advances in Polymer Science, 193(1), 173-198. https://doi.org/10.1007/12_028

Polymer genomics. / Kabanov, Alexander V.; Batrakova, Elena V.; Sherman, Simon; Alakhov, Valery Y.

In: Advances in Polymer Science, Vol. 193, No. 1, 01.12.2006, p. 173-198.

Research output: Contribution to journalReview article

Kabanov, AV, Batrakova, EV, Sherman, S & Alakhov, VY 2006, 'Polymer genomics', Advances in Polymer Science, vol. 193, no. 1, pp. 173-198. https://doi.org/10.1007/12_028
Kabanov AV, Batrakova EV, Sherman S, Alakhov VY. Polymer genomics. Advances in Polymer Science. 2006 Dec 1;193(1):173-198. https://doi.org/10.1007/12_028
Kabanov, Alexander V. ; Batrakova, Elena V. ; Sherman, Simon ; Alakhov, Valery Y. / Polymer genomics. In: Advances in Polymer Science. 2006 ; Vol. 193, No. 1. pp. 173-198.
@article{09f0698d81134f8189435ee018a81648,
title = "Polymer genomics",
abstract = "Biological activities of biocompatible synthetic polymers used in drug delivery, gene delivery, vaccine development or biomaterial surface modification are discussed. Synthetic polymers display selective phenotypic effects in cells and in the body, affecting signal transduction mechanisms involving inflammation, differentiation, proliferation, and apoptosis. These effects are realized as a result of interactions of water-soluble polymers with plasma cell membranes, delivery of polymers to intracellular organelles, and at the sites of cell contacts with polymer-coated surfaces. The ability of the cells and organisms to respond to the effects of these polymers can be dependent on phenotype or genotype. In selected cases, polymer agents can bypass limitations on biological response imposed by the genotype; for example, achievement of phenotypic correction of immune response by polyelectrolytes. Overall, these effects are relatively weak as they do not result in cytotoxicity or major toxicities in the body. However, when combined with specific biological agents, such as cytotoxic agents, bacterial DNA or antigens, either by mixing or by covalent conjugation, the polymers can drastically alter specific genetically controlled responses to these agents. Collectively these studies propose the need for thorough assessment of pharmacogenomic effects of polymer materials in order to maximize the clinical outcomes and understand the pharmacological and toxicological effects of polymer formulations of biological agents - polymer genomics.",
keywords = "Artificial vaccines, DNA microarray, Drug resistance, Phenotype, Signal transduction",
author = "Kabanov, {Alexander V.} and Batrakova, {Elena V.} and Simon Sherman and Alakhov, {Valery Y.}",
year = "2006",
month = "12",
day = "1",
doi = "10.1007/12_028",
language = "English (US)",
volume = "193",
pages = "173--198",
journal = "Advances in Polymer Science",
issn = "0065-3195",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Polymer genomics

AU - Kabanov, Alexander V.

AU - Batrakova, Elena V.

AU - Sherman, Simon

AU - Alakhov, Valery Y.

PY - 2006/12/1

Y1 - 2006/12/1

N2 - Biological activities of biocompatible synthetic polymers used in drug delivery, gene delivery, vaccine development or biomaterial surface modification are discussed. Synthetic polymers display selective phenotypic effects in cells and in the body, affecting signal transduction mechanisms involving inflammation, differentiation, proliferation, and apoptosis. These effects are realized as a result of interactions of water-soluble polymers with plasma cell membranes, delivery of polymers to intracellular organelles, and at the sites of cell contacts with polymer-coated surfaces. The ability of the cells and organisms to respond to the effects of these polymers can be dependent on phenotype or genotype. In selected cases, polymer agents can bypass limitations on biological response imposed by the genotype; for example, achievement of phenotypic correction of immune response by polyelectrolytes. Overall, these effects are relatively weak as they do not result in cytotoxicity or major toxicities in the body. However, when combined with specific biological agents, such as cytotoxic agents, bacterial DNA or antigens, either by mixing or by covalent conjugation, the polymers can drastically alter specific genetically controlled responses to these agents. Collectively these studies propose the need for thorough assessment of pharmacogenomic effects of polymer materials in order to maximize the clinical outcomes and understand the pharmacological and toxicological effects of polymer formulations of biological agents - polymer genomics.

AB - Biological activities of biocompatible synthetic polymers used in drug delivery, gene delivery, vaccine development or biomaterial surface modification are discussed. Synthetic polymers display selective phenotypic effects in cells and in the body, affecting signal transduction mechanisms involving inflammation, differentiation, proliferation, and apoptosis. These effects are realized as a result of interactions of water-soluble polymers with plasma cell membranes, delivery of polymers to intracellular organelles, and at the sites of cell contacts with polymer-coated surfaces. The ability of the cells and organisms to respond to the effects of these polymers can be dependent on phenotype or genotype. In selected cases, polymer agents can bypass limitations on biological response imposed by the genotype; for example, achievement of phenotypic correction of immune response by polyelectrolytes. Overall, these effects are relatively weak as they do not result in cytotoxicity or major toxicities in the body. However, when combined with specific biological agents, such as cytotoxic agents, bacterial DNA or antigens, either by mixing or by covalent conjugation, the polymers can drastically alter specific genetically controlled responses to these agents. Collectively these studies propose the need for thorough assessment of pharmacogenomic effects of polymer materials in order to maximize the clinical outcomes and understand the pharmacological and toxicological effects of polymer formulations of biological agents - polymer genomics.

KW - Artificial vaccines

KW - DNA microarray

KW - Drug resistance

KW - Phenotype

KW - Signal transduction

UR - http://www.scopus.com/inward/record.url?scp=33751557675&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751557675&partnerID=8YFLogxK

U2 - 10.1007/12_028

DO - 10.1007/12_028

M3 - Review article

AN - SCOPUS:33751557675

VL - 193

SP - 173

EP - 198

JO - Advances in Polymer Science

JF - Advances in Polymer Science

SN - 0065-3195

IS - 1

ER -